Extracorporeal Membrane Oxygenation Market Report and Forecast 2023-2031

The global Extracorporeal Membrane Oxygenation market value was USD 230.6 million in 2022, driven by the increasing prevalence of respiratory and cardiac diseases across the globe. The market size is anticipated to grow at a CAGR of 4.80% during the forecast period of 2023-2031 to achieve a value of USD 351.7 million by 2031.

Extracorporeal Membrane Oxygenation Introduction

Extracorporeal membrane oxygenation (ECMO) is a life support technique used for critically ill patients with heart and/or lung failure. ECMO involves removing blood from the body, running it through a machine that oxygenates and removes carbon dioxide, and then returning it to the patient. The use of ECMO has become increasingly common in the management of acute respiratory distress syndrome (ARDS) and cardiac failure. It has been particularly useful during the COVID-19 pandemic for patients with severe respiratory failure.

ECMO is a complex and resource-intensive therapy that requires specialized training and equipment. The market for ECMO devices includes oxygenators, centrifugal pumps, heat exchangers, and cannulas. The demand for ECMO devices and services has increased in recent years, driven by the growing prevalence of ARDS and cardiac failure. The market is expected to continue growing as the technology improves and more healthcare providers become trained in its use.

Key trends in the ECMO market include the development of new ECMO technologies that are more efficient, less invasive, and easier to use. There is also a growing trend towards the use of mobile ECMO units that can be used in a variety of healthcare settings, including emergency departments and transport vehicles. Additionally, there is a focus on improving patient outcomes through the development of standardized protocols and the use of data analytics to identify best practices.

Extracorporeal Membrane Oxygenation Market Scenario

Extracorporeal Membrane Oxygenation (ECMO) is a life-saving medical technique used to provide respiratory and/or cardiac support to critically ill patients. It involves using an external pump and oxygenator to circulate blood outside the body, allowing the lungs and/or heart to rest and heal. ECMO is typically used for patients with severe respiratory or cardiac failure, such as those with acute respiratory distress syndrome (ARDS) or cardiogenic shock.

The global ECMO market is expected to grow significantly in the coming years, driven by factors such as the increasing prevalence of respiratory and cardiac diseases, growing demand for advanced medical technologies, and a rise in the number of ECMO procedures being performed worldwide. Moreover, advancements in technology and medical devices are expected to further boost the market growth.

However, the high cost associated with ECMO devices, limited availability of skilled professionals, and ethical concerns regarding the use of such devices in critically ill patients are some of the key factors that may hinder market growth. Nonetheless, increasing investments by governments and private organizations in the healthcare sector and rising awareness about the benefits of ECMO therapy are expected to create significant growth opportunities in the coming years.

Extracorporeal Membrane Oxygenation Market Segmentations

Market Breakup by Component

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

Market Breakup by Modality

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

Market Breakup by Patient Type

• Neonates
• Pediatric
• Adult

Market Breakup by Application

• Respiratory
• Cardiac
• Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Market Breakup by Region

North America

• United States of America
• Canada

Europe

• United Kingdom
• Germany
• France
• Italy
• Others

Asia Pacific

• China
• Japan
• India
• ASEAN
• Australia
• Others

Latin America

• Brazil
• Argentina
• Mexico
• Others

Middle East and Africa

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Key Trends in the Extracorporeal Membrane Oxygenation Market

Some key trends in the extracorporeal membrane oxygenation (ECMO) market include:

• Increasing demand for ECMO in the treatment of COVID-19 patients with respiratory failure
• Technological advancements in ECMO systems, such as portable and miniaturized devices, that enhance patient outcomes and convenience
• Growing use of ECMO in the treatment of cardiac and respiratory conditions, including acute respiratory distress syndrome (ARDS) and heart failure
• Expansion of ECMO services in emerging markets due to rising healthcare investments and improving healthcare infrastructure
• Increasing adoption of veno-arterial ECMO over veno-venous ECMO for cardiac arrest and cardiogenic shock cases
• Rising collaborations and partnerships between ECMO device manufacturers and hospitals to improve patient care and research outcomes

Extracorporeal Membrane Oxygenation: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Medtronic PLC
• LivaNova PLC
• Terumo Corporation
• MicroPort Scientific Corporation
• Getinge AB
• Maquet Holding
• Medos Medizintechnik
• Nipro Medical Corporation
• CytoSorbents Corporation
• EUROSETS S.R.L